Two Sigma Advisers’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,591
Closed -$2.27M 1399
2025
Q4
$2.27M Sell
16,591
-18,841
-53% -$2.43M ﹤0.01% 1133
2025
Q3
$4.31M Sell
35,432
-4,559
-11% -$492K 0.01% 804
2025
Q2
$4.28M Sell
39,991
-314
-0.8% -$31.4K 0.01% 790
2025
Q1
$3.74M Buy
40,305
+37,705
+1,450% +$3.65M 0.01% 895
2024
Q4
$280K Sell
2,600
-700
-21% -$85.2K ﹤0.01% 2009
2024
Q3
$415K Sell
3,300
-100
-3% -$12.6K ﹤0.01% 1776
2024
Q2
$369K Sell
3,400
-300
-8% -$29.2K ﹤0.01% 1993
2024
Q1
$350K Sell
3,700
-11,191
-75% -$1.06M ﹤0.01% 2013
2023
Q4
$1.38M Sell
14,891
-18,500
-55% -$1.42M ﹤0.01% 1476
2023
Q3
$2.14M Sell
33,391
-9,000
-21% -$577K 0.01% 1166
2023
Q2
$2.62M Sell
42,391
-4,600
-10% -$273K 0.01% 1051
2023
Q1
$2.73M Buy
46,991
+20,500
+77% +$1.18M 0.01% 1104
2022
Q4
$1.58M Buy
26,491
+5,900
+29% +$358K ﹤0.01% 1358
2022
Q3
$1.3M Buy
20,591
+11,500
+126% +$799K ﹤0.01% 1387
2022
Q2
$635K Buy
9,091
+1,200
+15% +$84K ﹤0.01% 1820
2022
Q1
$554K Buy
7,891
+2,900
+58% +$195K ﹤0.01% 1929
2021
Q4
$339K Buy
4,991
+1,400
+39% +$96.9K ﹤0.01% 2099
2021
Q3
$251K Sell
3,591
-300
-8% -$21.8K ﹤0.01% 2179
2021
Q2
$272K Sell
3,891
-1,200
-24% -$87.2K ﹤0.01% 2172
2021
Q1
$397K Sell
5,091
-1,500
-23% -$106K ﹤0.01% 2108
2020
Q4
$438K Sell
6,591
-4,600
-41% -$303K ﹤0.01% 1913
2020
Q3
$697K Sell
11,191
-2,000
-15% -$125K ﹤0.01% 1670
2020
Q2
$837K Buy
13,191
+1,100
+9% +$73.7K ﹤0.01% 1669
2020
Q1
$867K Buy
12,091
+2,500
+26% +$198K ﹤0.01% 1565
2019
Q4
$829K Buy
9,591
+500
+5% +$41.8K ﹤0.01% 1661
2019
Q3
$744K Hold
9,091
﹤0.01% 1560
2019
Q2
$738K Hold
9,091
﹤0.01% 1655
2019
Q1
$690K Sell
9,091
-5,700
-39% -$452K ﹤0.01% 1668
2018
Q4
$1.16M Sell
14,791
-1,800
-11% -$141K ﹤0.01% 1418
2018
Q3
$1.25M Sell
16,591
-600
-3% -$44.1K ﹤0.01% 1427
2018
Q2
$1.21M Buy
17,191
+1,100
+7% +$72K ﹤0.01% 1531
2018
Q1
$960K Buy
16,091
+3,600
+29% +$221K ﹤0.01% 1561
2017
Q4
$761K Buy
12,491
+800
+7% +$51K ﹤0.01% 1619
2017
Q3
$732K Buy
11,691
+8,400
+255% +$541K ﹤0.01% 1606
2017
Q2
$231K Buy
+3,291
New +$235K ﹤0.01% 2080
2016
Q4
Sell
-7,691
Closed -$508K 2416
2016
Q3
$508K Sell
7,691
-2,300
-23% -$149K ﹤0.01% 1673
2016
Q2
$647K Buy
9,991
+4,700
+89% +$298K ﹤0.01% 1383
2016
Q1
$330K Buy
5,291
+300
+6% +$18.7K ﹤0.01% 1625
2015
Q4
$308K Sell
4,991
-100
-2% -$6.48K ﹤0.01% 1511
2015
Q3
$310K Buy
5,091
+200
+4% +$12.5K ﹤0.01% 1484
2015
Q2
$318K Buy
4,891
+100
+2% +$6.35K ﹤0.01% 1596
2015
Q1
$305K Sell
4,791
-1,000
-17% -$63.5K ﹤0.01% 1575
2014
Q4
$364K Sell
5,791
-200
-3% -$12K ﹤0.01% 1825
2014
Q3
$333K Sell
5,991
-300
-5% -$16.9K ﹤0.01% 1794
2014
Q2
$354K Sell
6,291
-100
-2% -$5.45K ﹤0.01% 1901
2014
Q1
$357K Sell
6,391
-400
-6% -$21K ﹤0.01% 1761
2013
Q4
$366K Buy
6,791
+2,400
+55% +$123K ﹤0.01% 1788
2013
Q3
$207K Buy
+4,391
New +$210K ﹤0.01% 1913

Other funds holding NHC

Two Sigma Advisers's NHC Position: Q1 2026 in Review

Two Sigma Advisers sold out of National Healthcare (NHC) in Q1 2026, closing a stake of 16,591 shares — an estimated $2.27M sold.

Two Sigma Advisers first reported a position in NHC in Q3 2013 and held it in 48 quarters. The position peaked at $4.31M in Q3 2025. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Two Sigma Advisers reported no remaining National Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 16,591 National Healthcare shares in Q1 2026, an estimated $2.27M.
  • Two Sigma Advisers first reported a position in National Healthcare in Q3 2013 and held it in 48 quarters.
  • Two Sigma Advisers's National Healthcare position peaked at $4.31M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.